| |
|
|
|
|
|
|
|||
|
Blood, 5 November 2009, Vol. 114, No. 19, pp. 4221-4232. Prepublished online as a Blood First Edition Paper on September 1, 2009; DOI 10.1182/blood-2009-03-209932.
PLATELETS AND THROMBOPOIESIS MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP91 Inserm, U790, Villejuif; 2 Université Paris XI, Villejuif; 3 Institut Gustave Roussy, IFR54, Villejuif; 4 Centre National de la Recherche Scientifique, FRE2939, Villejuif; and 5 Inserm, Hôpital Necker, Paris, France
Megakaryoblastic leukemia 1 (MAL) is a transcriptional coactivator of serum response factor (SRF). In acute megakaryoblastic leukemia, the MAL gene is translocated and fused with the gene encoding one twenty-two (OTT). Herein, we show that MAL expression increases during the late differentiation steps of neonate and adult human megakaryopoiesis and localized into the nucleus after Rho GTPase activation by adhesion on collagen I or convulxin. MAL knockdown in megakaryocyte progenitors reduced the percentage of cells forming filopodia, lamellipodia, and stress fibers after adhesion on the same substrates, and reduced proplatelet formation. MAL repression led to dysmorphic megakaryocytes with disorganized demarcation membranes and
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||